Effective long-term treatment of pseudohypoparathyroidism with oral 1alpha-hydroxy- and 1,25-dihydroxy-cholecalciferol.
D000284:Administration, Oral; D000328:Adult; D000469:Alkaline Phosphatase / Q000097:blood; D002118:Calcium / Q000097:blood; D002648:Child; D002675:Child, Preschool; D004100:Dihydroxycholecalciferols / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D006887:Hydroxycholecalciferols / Q000627:therapeutic use*; D008297:Male; D010281:Parathyroid Hormone / Q000097:blood; D010758:Phosphorus / Q000097:blood; D011547:Pseudohypoparathyroidism / Q000097:blood / Q000188:drug therapy* / Q000235:genetics; D011556:Pseudopseudohypoparathyroidism / Q000235:genetics; D013972:Thyrotropin / Q000097:blood; D013974:Thyroxine / Q000097:blood
D004100:Dihydroxycholecalciferols; D006887:Hydroxycholecalciferols; D010281:Parathyroid Hormone; D010758:Phosphorus; D013972:Thyrotropin; D000469:Alkaline Phosphatase; D013974:Thyroxine; D002118:Calcium